Secondary Antibodies Market Analysis - Global Industry Size, Share, Trends and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC808

Introduction

Primary antibodies are binded by secondary antibodies to support in detection, purification and sorting of aimed antigens. Secondary antibody is particularly effective in immune labeling. Secondary antibodies assistances in increasing signal amplification and sensitivity owing to its property of binding to primary antibodies. Secondary antibodies can consolidate to enzymes such as alkaline phosphatase (AP) or horseradish peroxidase (HRP).

Market Dynamics

Increased expenses in the life science sector, rising association between academic and industries, institutes, growing R&D activities are some of the factors driving the growth of this market. Conversely, vast technical demand and high cost are impeding growth of secondary antibodies market. High growth in the emerging countries and growing demand for modified medicine are expected to propel growth of this market in near future.

Market Classification

The market can be bifurcated on the basis of application, product and geography. By application, secondary antibodies market can be segmented into ELISA, western blot, immunostaining, immunohistochemistry and immunocytochemistry. By product, secondary antibodies market can be segmented into men' and animals'. On the basis of geography, the secondary antibodies market can be segmented into North America, Latin America, Europe, Middle East & Africa (MEA) and Asia-Pacific.

Report Coverage

Market

Secondary Antibodies Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

Application, Product, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis,

Competitive Analysis, Player Profiling, Value Chain Analysis

 

Market Participants

Some of the major players involved in secondary antibodies market include EMD Millipore, Rockland Immuno Chemicals, Kirkegaard & Perry Laboratories, R&D Systems, BioLegend, Acris Antibodies, Sino Biological and BioLogo among others.

Market Segmentation

Market By Application

  • ELISA (Including Many HIV Tests)
  • Western Blot
  • Immunostaining
  • Immunohistochemistry
  • Immunocytochemistry

Market By Product

  • Men'
  • Animals'

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of LATAM
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

 


Related Reports

Macular Degeneration Treatment Market (By Disease Indication: Dry Age-related Macular Degeneration Treatment, Wet Age-related Macular Degeneration Treatment, Others; By Drug Class: Anti-vascular endothelial growth factor, Others; By End-user: Ambulatory Surgical Centers, Hospitals, Ophthalmic Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global macular degeneration treatment Market is estimated to value US$ 11.4 Billion by 2026 and the market is projected to showcase 6.6% CAGR during the forecast period. The macular degeneration treatment market is driven by surge in healthcare spending and improved in healthcare infrastructure. Market D

Gynecological Devices Market (By Device: Surgical Devices [Endoscopy Devices, Fluid Management Systems, Endometrial Ablation Devices, Contraceptive Devices, Others], Diagnostic Imaging Systems [Ultrasound, Mammography, MRI, Others], Hand Held Instruments [Biopsy Forceps, Tenaculum, Curettes, Others], Software, Others; By End-Users: Hospitals, Clinics, Diagnostic Centres, Research Institutes, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global Gynecological Devices market was valued at $9.4 billion in 2018 and is anticipated to grow at a CAGR of 7.9% during the forecast period. Gynecological devices include instruments and devices used for the treatment of diseases related to the female reproductive system. These devices include surgical devices, handheld instruments, diagnostic i

Transfusion Technology Market (By Product: Instruments [Apheresis System & Multicomponent Collection Systems, Cell Processing Systems & Cell Expansion Systems, Auto Transfusion Devices, Others], Disposables & Consumables; By End-user: Hospitals, Blood Banks, Biotechnology & Pharmaceutical Companies, Others ) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The international transfusion technology market’s worth is likely to touch USD 7,138 Million by 2026 and the market is expected to project a CAGR of 5.4% during the upcoming years. Market Dynamics The worldwide transfusion technology market is described by

Lyophilized Injectable Drugs Market (By Packaging Type: Specialty Packaging, Point-Of-Care Reconstitution, Single-Use Vials, Others; By Type of Delivery: Single-step Devices, Multi-step Devices, Prefilled Diluent Syringes, Proprietary Reconstitution Devices; By Indication: Infectious Diseases, Autoimmune Diseases, Metabolic Conditions, Others; By End-user: Ambulatory Surgical Centers, Hospitals, Specialty Clinics, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global lyophilized injectable drugs market is projected to worth $4,350.3 Million by 2026 and the market is projected to showcase 6.9% CAGR during the forecast period. The lyophilized injectable drugs market is expected to grow at a rapid pace owing to the increase in development of pipeline of lyophilized injectable drugs.

Cardiac Ablation Technologies Market (By Technology Type: Radiofrequency, Cryoablation, Laser, Ultrasound, Microwave, Others; By Application: Atrial fibrillation, Ventricular Tachycardia, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global cardiac ablation technologies Market is project worth US$ 3,450.5 Million in 2017 and the market is projected to showcase 11.4% CAGR during the forecast period. The cardiac ablation technologies market is driven by rising incidence of atrial fibrillation and technological advancement. Market Dynam

Cart Summary